The last frontier: transcatheter devices for percutaneous or minimally invasive treatment of chronic heart failure

Heart failure has a high prevalence in the general population. Morbidity and mortality of heart failure patients remain high, despite improvements in drug therapy, implantable cardioverter-defibrillators and cardiac resynchronisation therapy. New transcatheter implantable devices have been developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Nijenhuis, V. J., Sanchis, L., van der Heyden, J. A. S., Klein, P., Rensing, B. J. W. M., Latib, A., Maisano, F., ten Berg, J. M., Agostoni, P., Swaans, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2017
Materias:
Review Article - Point of View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612866/
https://www.ncbi.nlm.nih.gov/pubmed/28741245
http://dx.doi.org/10.1007/s12471-017-1018-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612866/
https://www.ncbi.nlm.nih.gov/pubmed/28741245
http://dx.doi.org/10.1007/s12471-017-1018-8

Ejemplares similares